| Status: Under consideration by AWMSG Scrutiny Panel | |
For the prevention of stroke after previous minor ischaemic stroke or transient ischaemic attack in patients unsuitable for clopidogrel, in the acute phase and for long term secondary prevention (off label use). |
|
Medicine details |
|
| Medicine name | ticagrelor |
| Formulation | 60 mg and 90 mg oral tablet |
| Reference number | 3882 |
| Indication | as above |
| BNF chapter | Cardiovascular system |
| Assessment type | Under consideration |
| Status | Under consideration by AWMSG Scrutiny Panel |
| Advice number | 3882 |
| Scrutiny Panel meeting date | 15/10/2026 |